ARCOSA INC (ACA) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:ACA - US0396531008 - Common Stock
106.54 USD
+0.12 (+0.11%)
106.54 USD
0 (0%)
ACA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 55 industry peers in the Construction & Engineering industry. ACA has only an average score on both its financial health and profitability. ACA is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year ACA was profitable.
In the past year ACA had a positive cash flow from operations.
In the past 5 years ACA has always been profitable.
ACA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of 2.94%, ACA perfoms like the industry average, outperforming 50.91% of the companies in the same industry.
ACA has a Return On Equity of 5.75%. This is comparable to the rest of the industry: ACA outperforms 41.82% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.99%, ACA is in line with its industry, outperforming 45.45% of the companies in the same industry.
ACA had an Average Return On Invested Capital over the past 3 years of 3.99%. This is significantly below the industry average of 17.30%.
The last Return On Invested Capital (4.99%) for ACA is above the 3 year average (3.99%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.94% | ||
| ROE | 5.75% | ||
| ROIC | 4.99% |
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
1.3 Margins
With a decent Profit Margin value of 5.25%, ACA is doing good in the industry, outperforming 65.45% of the companies in the same industry.
In the last couple of years the Profit Margin of ACA has declined.
With a decent Operating Margin value of 10.27%, ACA is doing good in the industry, outperforming 74.55% of the companies in the same industry.
ACA's Operating Margin has declined in the last couple of years.
The Gross Margin of ACA (21.61%) is better than 63.64% of its industry peers.
In the last couple of years the Gross Margin of ACA has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.27% | ||
| PM (TTM) | 5.25% | ||
| GM | 21.61% |
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACA is destroying value.
ACA has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ACA has more shares outstanding
Compared to 1 year ago, ACA has a worse debt to assets ratio.
2.2 Solvency
ACA has an Altman-Z score of 2.41. This is not the best score and indicates that ACA is in the grey zone with still only limited risk for bankruptcy at the moment.
ACA has a Altman-Z score (2.41) which is comparable to the rest of the industry.
ACA has a debt to FCF ratio of 5.03. This is a neutral value as ACA would need 5.03 years to pay back of all of its debts.
ACA has a better Debt to FCF ratio (5.03) than 61.82% of its industry peers.
ACA has a Debt/Equity ratio of 0.61. This is a neutral value indicating ACA is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.61, ACA perfoms like the industry average, outperforming 58.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 5.03 | ||
| Altman-Z | 2.41 |
ROIC/WACC0.49
WACC10.1%
2.3 Liquidity
A Current Ratio of 2.02 indicates that ACA has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.02, ACA belongs to the top of the industry, outperforming 89.09% of the companies in the same industry.
ACA has a Quick Ratio of 1.30. This is a normal value and indicates that ACA is financially healthy and should not expect problems in meeting its short term obligations.
ACA has a Quick ratio of 1.30. This is comparable to the rest of the industry: ACA outperforms 58.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.02 | ||
| Quick Ratio | 1.3 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 17.03% over the past year.
ACA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.16% yearly.
The Revenue has grown by 13.96% in the past year. This is quite good.
ACA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.15% yearly.
EPS 1Y (TTM)17.03%
EPS 3Y16.17%
EPS 5Y5.16%
EPS Q2Q%71.43%
Revenue 1Y (TTM)13.96%
Revenue growth 3Y8.06%
Revenue growth 5Y8.15%
Sales Q2Q%24.58%
3.2 Future
The Earnings Per Share is expected to grow by 20.31% on average over the next years. This is a very strong growth
Based on estimates for the next years, ACA will show a small growth in Revenue. The Revenue will grow by 7.30% on average per year.
EPS Next Y36.06%
EPS Next 2Y24.91%
EPS Next 3Y20.31%
EPS Next 5YN/A
Revenue Next Year10.62%
Revenue Next 2Y8.3%
Revenue Next 3Y7.3%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 28.19, which means the current valuation is very expensive for ACA.
Based on the Price/Earnings ratio, ACA is valued a bit cheaper than 69.09% of the companies in the same industry.
ACA's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.31.
A Price/Forward Earnings ratio of 22.68 indicates a rather expensive valuation of ACA.
ACA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ACA is cheaper than 69.09% of the companies in the same industry.
ACA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 36.59.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.19 | ||
| Fwd PE | 22.68 |
4.2 Price Multiples
ACA's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ACA is cheaper than 80.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ACA is valued cheaper than 83.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.61 | ||
| EV/EBITDA | 12.73 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ACA's earnings are expected to grow with 20.31% in the coming years.
PEG (NY)0.78
PEG (5Y)5.46
EPS Next 2Y24.91%
EPS Next 3Y20.31%
5. Dividend
5.1 Amount
With a yearly dividend of 0.20%, ACA is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.73, ACA pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, ACA's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.2% |
5.2 History
The dividend of ACA decreases each year by -0.48%.
ACA has been paying a dividend for over 5 years, so it has already some track record.
ACA has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)-0.48%
Div Incr Years0
Div Non Decr Years5
5.3 Sustainability
ACA pays out 6.66% of its income as dividend. This is a sustainable payout ratio.
DP6.66%
EPS Next 2Y24.91%
EPS Next 3Y20.31%
106.54
+0.12 (+0.11%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)
Earnings (Next)
Inst Owners95.34%
Inst Owner Change-4.45%
Ins Owners1.8%
Ins Owner Change-2%
Market Cap5.22B
Revenue(TTM)2.83B
Net Income(TTM)148.60M
Analysts86
Price Target122.23 (14.73%)
Short Float %2.41%
Short Ratio5.31
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.2% |
Yearly Dividend0.2
Dividend Growth(5Y)-0.48%
DP6.66%
Div Incr Years0
Div Non Decr Years5
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.63%
Min EPS beat(2)15.61%
Max EPS beat(2)17.65%
EPS beat(4)3
Avg EPS beat(4)38.79%
Min EPS beat(4)-40.32%
Max EPS beat(4)162.24%
EPS beat(8)7
Avg EPS beat(8)30.62%
EPS beat(12)11
Avg EPS beat(12)32.12%
EPS beat(16)15
Avg EPS beat(16)40.53%
Revenue beat(2)1
Avg Revenue beat(2)-1.27%
Min Revenue beat(2)-3.72%
Max Revenue beat(2)1.18%
Revenue beat(4)2
Avg Revenue beat(4)-1.29%
Min Revenue beat(4)-4.44%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.83%
Revenue beat(12)7
Avg Revenue beat(12)0.53%
Revenue beat(16)11
Avg Revenue beat(16)1.99%
PT rev (1m)3.3%
PT rev (3m)3.3%
EPS NQ rev (1m)4.43%
EPS NQ rev (3m)1.16%
EPS NY rev (1m)1.6%
EPS NY rev (3m)1.88%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-1.13%
Revenue NY rev (1m)0.38%
Revenue NY rev (3m)0.14%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 28.19 | ||
| Fwd PE | 22.68 | ||
| P/S | 1.84 | ||
| P/FCF | 16.61 | ||
| P/OCF | 11.13 | ||
| P/B | 2.02 | ||
| P/tB | 5.69 | ||
| EV/EBITDA | 12.73 |
EPS(TTM)3.78
EY3.55%
EPS(NY)4.7
Fwd EY4.41%
FCF(TTM)6.42
FCFY6.02%
OCF(TTM)9.57
OCFY8.98%
SpS57.77
BVpS52.71
TBVpS18.73
PEG (NY)0.78
PEG (5Y)5.46
Graham Number66.96
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.94% | ||
| ROE | 5.75% | ||
| ROCE | 6.5% | ||
| ROIC | 4.99% | ||
| ROICexc | 5.24% | ||
| ROICexgc | 8.62% | ||
| OM | 10.27% | ||
| PM (TTM) | 5.25% | ||
| GM | 21.61% | ||
| FCFM | 11.11% |
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
ROICexc(3y)4.17%
ROICexc(5y)4.21%
ROICexgc(3y)7.17%
ROICexgc(5y)7.33%
ROCE(3y)5.21%
ROCE(5y)5.27%
ROICexgc growth 3Y4.01%
ROICexgc growth 5Y-10.09%
ROICexc growth 3Y4.98%
ROICexc growth 5Y-11.63%
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
F-Score5
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 5.03 | ||
| Debt/EBITDA | 3.04 | ||
| Cap/Depr | 68.36% | ||
| Cap/Sales | 5.46% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 90.74% | ||
| Profit Quality | 211.71% | ||
| Current Ratio | 2.02 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 2.41 |
F-Score5
WACC10.1%
ROIC/WACC0.49
Cap/Depr(3y)104.81%
Cap/Depr(5y)89.02%
Cap/Sales(3y)7.45%
Cap/Sales(5y)6.15%
Profit Quality(3y)128.08%
Profit Quality(5y)133.99%
High Growth Momentum
Growth
EPS 1Y (TTM)17.03%
EPS 3Y16.17%
EPS 5Y5.16%
EPS Q2Q%71.43%
EPS Next Y36.06%
EPS Next 2Y24.91%
EPS Next 3Y20.31%
EPS Next 5YN/A
Revenue 1Y (TTM)13.96%
Revenue growth 3Y8.06%
Revenue growth 5Y8.15%
Sales Q2Q%24.58%
Revenue Next Year10.62%
Revenue Next 2Y8.3%
Revenue Next 3Y7.3%
Revenue Next 5YN/A
EBIT growth 1Y48.65%
EBIT growth 3Y20.99%
EBIT growth 5Y5.01%
EBIT Next Year133.35%
EBIT Next 3Y37.6%
EBIT Next 5YN/A
FCF growth 1Y5015.62%
FCF growth 3Y56.55%
FCF growth 5Y2.7%
OCF growth 1Y146.35%
OCF growth 3Y44.47%
OCF growth 5Y6.95%
ARCOSA INC / ACA FAQ
Can you provide the ChartMill fundamental rating for ARCOSA INC?
ChartMill assigns a fundamental rating of 5 / 10 to ACA.
What is the valuation status for ACA stock?
ChartMill assigns a valuation rating of 6 / 10 to ARCOSA INC (ACA). This can be considered as Fairly Valued.
Can you provide the profitability details for ARCOSA INC?
ARCOSA INC (ACA) has a profitability rating of 5 / 10.
What are the PE and PB ratios of ARCOSA INC (ACA) stock?
The Price/Earnings (PE) ratio for ARCOSA INC (ACA) is 28.19 and the Price/Book (PB) ratio is 2.02.
What is the expected EPS growth for ARCOSA INC (ACA) stock?
The Earnings per Share (EPS) of ARCOSA INC (ACA) is expected to grow by 36.06% in the next year.